Staar Surgical (STAA) Research & Development (2010 - 2026)
Staar Surgical's (STAA) quarterly Research & Development came in at $24.5 million in Q2 2026, down 9.04% YoY from $26.9 million in Q2 2025, and down 5.15% on a QoQ basis from $25.8 million in Q1 2026.
Staar Surgical (STAA) Research & Development (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has 17 years of Research & Development data on file, last reported at $24.5 million in Q2 2026.
- Quarterly Research & Development fell 9.04% year-over-year to $24.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $85.8 million (down 48.98% YoY) and the FY2026 annual result came in at $102.5 million, down 12.35% from the prior year.
- Research & Development retreated to $24.5 million in Q2 2026, from $25.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $81.4 million in Q4 2024 to a low of -$44.8 million in Q4 2023.
- A 5-year average of $22.4 million and a median of $25.8 million in 2026 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development plunged 284.78% — and 2024, when it jumped 281.93%.
- Tracing STAA's Research & Development over 5 years: stood at $24.2 million in 2022, then sank by 284.78% to -$44.8 million in 2023, then jumped by 281.93% to $81.4 million in 2024, then sank by 88.69% to $9.2 million in 2025, then surged by 166.14% to $24.5 million in 2026.
- The last three Research & Development figures came in at $24.5 million (Q2 2026), $25.8 million (Q1 2026), and $9.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Staar Surgical | 1.16 Bn | 979.42 Mn | 69.73 Mn | 26.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 26.94 Mn |
| Apr 3, 2026 | 24.51 Mn |
| Jan 2, 2026 | 25.84 Mn |
| Sep 26, 2025 | 9.21 Mn |
| Jun 27, 2025 | 26.28 Mn |
| Mar 28, 2025 | 26.95 Mn |
| Dec 27, 2024 | 81.43 Mn |
| Sep 27, 2024 | 28.87 Mn |
| Jun 28, 2024 | 31.01 Mn |
| Mar 29, 2024 | 13.38 Mn |
| Dec 29, 2023 | -44.76 Mn |
| Sep 29, 2023 | 26.61 Mn |
| Jun 30, 2023 | 32.28 Mn |
| Mar 31, 2023 | 26.35 Mn |
| Dec 30, 2022 | 24.22 Mn |
| Sep 30, 2022 | 23.13 Mn |
| Jul 1, 2022 | 8.64 Mn |
| Apr 1, 2022 | 17.27 Mn |
| Dec 31, 2021 | 42.50 Mn |
| Oct 1, 2021 | 8.27 Mn |